105
Participants
Start Date
June 30, 2013
Primary Completion Date
September 30, 2016
Study Completion Date
November 30, 2016
TauroSept®
"5 ml of TauroSept® will be instilled into the catheter (CVAD) each time after total parenteral nutrition (TPN) has been completed. The frequency of administration depends on the schedule of HPN. It varies between twice per week and once daily.~The duration of TauroSept® administration in this trial will be 12 months."
University Hospital Copenhagen Rigshospitalet, Copenhagen
University of Bologna Center for Chronic Intestinal Failure Department of Gastroenterology and Internal Medicine, Bologna
University Clinic Münster, Münster
Rabin Medical Center, Petah Tikva
Department of Gastroenterology and Hepatology clinical ward, Nijmegen
St Mark's Hospital, Harrow
University College Hospital, London
Collaborators (1)
Geistlich Pharma AG
INDUSTRY
Geert Wanten
OTHER